Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Plos One|December 31, 2013
TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysisQiliu Peng, Xianjun Lao, Zhiping Chen, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 9, 2013
The association of interleukin-16 gene polymorphisms with IL-16 serum levels and risk of nasopharyngeal carcinoma in a Chinese populationXue Qin, Qiliu Peng, Xiaoxia Lao, et al.Plos One|October 8, 2013
An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer riskXue Qin, Qiliu Peng, Weizhong Tang, et al.Clinical Laboratory|May 21, 2014
Determination of reference intervals for serum complement C3 and C4 levels in Chinese Han ethnic malesXue Qin, Yu Lu, Xiaoli Yang, et al.Molecular Medicine (Cambridge, Mass.)|May 13, 2022
Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomesZihan Zhou, Peifeng Li, Xianbin Zhang, et al.International Journal of Biological Macromolecules|September 6, 2023
Preparation of injectable porcine skin-derived collagen and its application in delaying skin aging by promoting the adhesion and chemotaxis of skin fibroblastsHe Ni, Chao Liu, Lili Kong, et al.Frontiers in Medicine|January 11, 2021
A Cohort Study of Liver Involvement in Patients With Adult-Onset Still's Disease: Prevalence, Characteristics and Impact on PrognosisHuihui Chi, Zhihong Wang, Jianfen Meng, et al.The Lancet Regional Health. Western Pacific|March 7, 2023
Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 studyYuankai Shi, Xintian Qin, Xingchen Peng, et al.Nature Medicine|June 28, 2024
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trialYuankai Shi, Wei Guo, Wei Wang, et al.Pageof 5